Used in peptide synthesis as a chiral building block, particularly in the preparation of modified amino acids for pharmaceutical research. Its structure allows for selective coupling reactions, making it valuable in the development of enzyme inhibitors and bioactive peptides. The fluorenylmethyloxycarbonyl (Fmoc) group enables orthogonal protection strategies in solid-phase peptide synthesis, while the carboxylic acid functionality supports attachment to resin supports or further derivatization. Commonly applied in the synthesis of complex therapeutic peptides and peptidomimetics where stereochemistry plays a critical role in biological activity.